Sterling Pharma Solutions signs up to manufacture OncoTEX's ovarian cancer drug
The CDMO's expertise and capabilities a "perfect fit" for overcoming the challenges of manufacturing this complex molecule
Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has signed a clinical development agreement with biotech OncoTex to manufacture its oncology drug candidate, OxaliTEX.
Sterling will produce clinical material in its cGMP facility in Germantown, Wisconsin, which can handle highly potent active pharmaceutical ingredients (HPAPIs) in fully contained manufacturing suites.
“The challenges involved in the manufacture of this complex molecule was a perfect fit for the expertise and capabilities that our team in Germantown have,” said Dr Andrew Henderson, Chief Commercial Officer at Sterling Pharma Solutions.
OxaliTEX, a conjugate of oxaliplatin -- a platinum-basd chemotherapy drug -- and a tumour-localising metallotexaphyrin, is the first candidate to emerge in a new class of oncology drugs that are tumour localising, well-tolerated, and overcome platinum-resistance. It is also MRI-detectable, allowing clinicians and patients to easily monitor tumour regression during treatment.
The drug candidate has been developed by OncoTEX using its proprietary oncology drug platform, TEX Core, to address the unmet clinical need in ovarian cancer diagnosis and treatment.
According to Dr Jonathan Arambula, Vice President of Research at OncoTEX, working with Sterling will enable them to produce OxaliTEX that meets the FDA regulatory requirements necessary for clinical use.
OncoTex is a member of The iQ Group Global, a consortium of companies which finds, funds and develops bioscience discoveries.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance